Beth N. McLellan

1.7k total citations
82 papers, 1000 citations indexed

About

Beth N. McLellan is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Beth N. McLellan has authored 82 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Dermatology, 33 papers in Oncology and 29 papers in Epidemiology. Recurrent topics in Beth N. McLellan's work include Chemotherapy-related skin toxicity (20 papers), Nonmelanoma Skin Cancer Studies (19 papers) and Melanoma and MAPK Pathways (10 papers). Beth N. McLellan is often cited by papers focused on Chemotherapy-related skin toxicity (20 papers), Nonmelanoma Skin Cancer Studies (19 papers) and Melanoma and MAPK Pathways (10 papers). Beth N. McLellan collaborates with scholars based in United States, Canada and Italy. Beth N. McLellan's co-authors include Alexandra K. Rzepecki, Mario E. Lacouture, Alana Deutsch, Holly Kerr, Fortunato Ciardiello, Eric Van Cutsem, Siegfried Segaert, Bijal Amin, Mark Jacobson and Sabrina G. Fabi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Beth N. McLellan

71 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth N. McLellan United States 16 435 416 234 143 127 82 1000
E. Puzenat France 18 577 1.3× 202 0.5× 200 0.9× 123 0.9× 122 1.0× 68 1.3k
Nigel Burrows United Kingdom 23 411 0.9× 290 0.7× 219 0.9× 240 1.7× 127 1.0× 84 1.7k
Alessandro Giunta Italy 18 422 1.0× 180 0.4× 75 0.3× 214 1.5× 74 0.6× 78 1.3k
B K Bang South Korea 17 520 1.2× 108 0.3× 102 0.4× 140 1.0× 86 0.7× 52 1.2k
S. Prey France 24 584 1.3× 607 1.5× 245 1.0× 242 1.7× 106 0.8× 64 2.1k
Anne Braae Olesen Denmark 28 1.0k 2.4× 362 0.9× 596 2.5× 158 1.1× 157 1.2× 55 1.9k
Irena Walecka Poland 14 294 0.7× 107 0.3× 135 0.6× 93 0.7× 47 0.4× 83 815
Katayoon Goodarzi United States 12 107 0.2× 375 0.9× 145 0.6× 147 1.0× 154 1.2× 27 1.6k
Yoshinori Umezawa Japan 23 551 1.3× 98 0.2× 111 0.5× 124 0.9× 41 0.3× 71 1.3k
Prabha Ranganathan United States 20 114 0.3× 103 0.2× 250 1.1× 143 1.0× 62 0.5× 53 1.3k

Countries citing papers authored by Beth N. McLellan

Since Specialization
Citations

This map shows the geographic impact of Beth N. McLellan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth N. McLellan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth N. McLellan more than expected).

Fields of papers citing papers by Beth N. McLellan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth N. McLellan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth N. McLellan. The network helps show where Beth N. McLellan may publish in the future.

Co-authorship network of co-authors of Beth N. McLellan

This figure shows the co-authorship network connecting the top 25 collaborators of Beth N. McLellan. A scholar is included among the top collaborators of Beth N. McLellan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth N. McLellan. Beth N. McLellan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, Alice J., et al.. (2025). Genitourinary syndrome of menopause: An important diagnosis for dermatologists. Journal of the American Academy of Dermatology. 93(3). 742–744. 1 indexed citations
2.
Deutsch, Alana, et al.. (2025). Palliative oncodermatology: Management of malignancy-related cutaneous symptoms in the palliative care setting. Journal of the American Academy of Dermatology. 92(6). 1351–1359.
3.
Florez, Narjust, Nicole R. LeBoeuf, Julia Rotow, et al.. (2025). Mitigation and management of adverse events associated with amivantamab therapy. The Oncologist. 30(7).
4.
Amin, Bijal, et al.. (2025). Pemphigoid gestationis associated with gestational trophoblastic neoplasia: A case report. Gynecologic Oncology Reports. 59. 101771–101771.
5.
McLellan, Beth N., et al.. (2023). Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies. American Journal of Clinical Dermatology. 24(5). 765–785. 1 indexed citations
6.
McLellan, Beth N., et al.. (2022). Safe use of donated positive airway pressure devices to increase access to treatment for obstructive sleep apnea: a clinical outreach program. Journal of Clinical Sleep Medicine. 18(5). 1455–1457. 1 indexed citations
7.
McLellan, Beth N., et al.. (2022). The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation. Frontiers in Endocrinology. 13. 841889–841889. 13 indexed citations
8.
Deutsch, Alana, et al.. (2022). Single-Cell Characterization of Lipomas and Identification of their Adipogenic Progenitors: A Transcriptomic Assessment. Journal of Investigative Dermatology. 142(9). 2518–2521.e2.
9.
Lacouture, Mario E., Jennifer Choi, Alice Y. Ho, et al.. (2021). US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm. Journal of Drugs in Dermatology. 20(9). 3ss–s19. 5 indexed citations
10.
McLellan, Beth N., et al.. (2020). Use of positive airway pressure in mild cognitive impairment to delay progression to dementia. Journal of Clinical Sleep Medicine. 16(6). 863–870. 20 indexed citations
11.
Deutsch, Alana & Beth N. McLellan. (2020). Topical tacrolimus for refractory superficial mucoceles in a patient with chronic graft versus host disease. JAAD Case Reports. 6(5). 426–427. 3 indexed citations
12.
Damanpour, Shadi, et al.. (2020). Social media activity is associated with higher physician ratings by patients. Journal of the American Academy of Dermatology. 84(5). 1455–1458. 3 indexed citations
13.
Deutsch, Alana & Beth N. McLellan. (2020). Severe onycholysis and eyelash trichomegaly in a patient treated with erdafitinib. JAAD Case Reports. 6(6). 569–571. 5 indexed citations
14.
Deutsch, Alana, Nicole R. LeBoeuf, Mario E. Lacouture, & Beth N. McLellan. (2020). Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy. American Society of Clinical Oncology Educational Book. 40(40). 485–500. 45 indexed citations
15.
Chennupati, S.K., et al.. (2019). Referral practices to dermatologists for the treatment of radiation dermatitis in the USA: a call for a multidisciplinary approach. Supportive Care in Cancer. 28(3). 967–969. 9 indexed citations
16.
Rzepecki, Alexandra K., et al.. (2019). Estrogen-deficient skin: The role of topical therapy. International Journal of Women’s Dermatology. 5(2). 85–90. 59 indexed citations
17.
Rzepecki, Alexandra K., et al.. (2019). A unique clinical and histologic presentation of catastrophic systemic calciphylaxis in a nonuremic patient with systemic lupus erythematosus. JAAD Case Reports. 5(3). 245–248. 1 indexed citations
18.
Rzepecki, Alexandra K., et al.. (2018). A National Survey of Medical Coding and Billing Training in United States Dermatology Residency Programs.. PubMed. 17(6). 678–682. 10 indexed citations
19.
Rzepecki, Alexandra K., Haiying Cheng, & Beth N. McLellan. (2018). Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy. Journal of the American Academy of Dermatology. 79(3). 545–555. 29 indexed citations
20.
Michelle, W., et al.. (2017). Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma. JAAD Case Reports. 3(3). 208–211. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Puzenat Breakdown of academic impact, for papers by Nigel Burrows Breakdown of academic impact, for papers by Alessandro Giunta Breakdown of academic impact, for papers by B K Bang Breakdown of academic impact, for papers by S. Prey Breakdown of academic impact, for papers by Anne Braae Olesen Breakdown of academic impact, for papers by Irena Walecka Breakdown of academic impact, for papers by Katayoon Goodarzi Breakdown of academic impact, for papers by Yoshinori Umezawa Breakdown of academic impact, for papers by Prabha Ranganathan
Rankless by CCL
2026